A Multi-center,_double-blind,_pararel-group Comparison Trial to Investigate the Effect of Short-term Administration of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients (Phase_4 Study)
Phase of Trial: Phase IV
Latest Information Update: 18 Jan 2018
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 10 Jun 2017 Biomarkers information updated
- 06 Aug 2014 Last checked against ClinicalTrials.gov record.
- 10 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.